...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.
【24h】

Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.

机译:Mn(II),Co(II)和Zn(II)配合物与杂环取代的硫代半氨基甲酮类化合物的合成,表征,X射线晶体结构和抗肿瘤比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Transition metal complexes Mn(L(1))(2) (1), Mn(L(2))(2) (2), Co(L(3))(2)Cl 4H(2)O (3), Zn(L(3))(2) DMF (4), Co(HL(4))(2)(ClO(4))(2) 3H(2)O (5) and Zn(L(5))(2) DMF (6) where HL(1)=2-acetylpyridine thiosemicarbazone, HL(2)=2-acetylpyridine N(4)-methylthiosemicarbazone, HL(3)=2-benzoylpyridine thiosemicarbazone, HL(4)=2-benzoylpyridine N(4)-methylthiosemicarbazone and HL(5)=2-benzoylpyridine N(4)-phenylthiosemicarbazone, have been synthesized. The complexes 1, 2, 5 and 6 were characterized by elemental analysis, IR spectra and single-crystal X-ray diffraction studies. Preliminary in vitro screening indicated that all the tested compounds showed significant antitumor activity against K562 leucocythemia cancer cell line.
机译:过渡金属配合物Mn(L(1))(2)(1),Mn(L(2))(2)(2),Co(L(3))(2)Cl 4H(2)O(3) ,Zn(L(3))(2)DMF(4),Co(HL(4))(2)(ClO(4))(2)3H(2)O(5)和Zn(L(5) )(2)DMF(6),其中HL(1)= 2-乙酰基吡啶硫半卡巴a,HL(2)= 2-乙酰基吡啶N(4)-甲基硫代半碳巴zone,HL(3)= 2-苯甲酰基吡啶硫代半碳巴,, HL(4)= 2已合成了-苯甲酰基吡啶N(4)-甲基硫代半碳and和HL(5)= 2-苯甲酰基吡啶N(4)-苯基硫代半碳zone。配合物1、2、5和6通过元素分析,红外光谱和单晶X射线衍射研究进行了表征。初步的体外筛选表明,所有测试的化合物均显示出对K562白细胞增多症癌细胞系的显着抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号